Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cryoport, Inc. Director's Dealing 2021

Mar 12, 2021

32876_dirs_2021-03-11_3039087f-7aab-4835-b6aa-3f9303e430f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-03-09

Reporting Person: STEFANOVICH ROBERT (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-09 Option to purchase common stock $58.94 A 21333 Acquired 2028-03-09 Common Stock (21333) Direct
2021-03-09 Restricted Stock Rights $ A 10667 Acquired Common Stock (10667) Direct

Footnotes

F1: 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021.

F2: Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3: The restricted stock rights vest in four equal annual installments beginning 3/9/2022.